Cagrilintide

Price range: $57.00 through $105.00

+ $9.99 Shipping
Product specifications
  • Product: Cagrilintide
  • Purity: ≥99% purity
  • Class: Amylin Receptor Agonist
  • Form: Lyophilized powder
  • CAS: 1415456-99-3
  • Molecular Weight: 3754.3 Da
  • Storage: Store at -20°C (long term). Refrigerate after reconstitution.
  • Use: For in-vitro research use only. Not for human consumption.

Research Use Only. Not for Human Consumption.

Secure checkout
Verified Purity
HPLC + Mass Spec Tested
Secure SSL Checkout

Batch documentation

Certificate of analysis

COA library

Apex Laboratory results for the listed configurations. Match the lot on your label with the report.

Cagrilintide - 10 mg

Lot
APX-2026-0816-C
COA issued
Aug 16, 2026
Issuing laboratory
Apex Laboratory
Cagrilintide chromatographic purity
99.941 % integrated detector area
Cagrilintide active content
10.0032 mg/vial
Amylin receptor cAMP response relative potency
100.05 % reference response potency
Bacterial endotoxins
<0.025 EU/mg active-equivalent

Chromatographic purity by analyte

Chromatographic purity by analyte for Cagrilintide - 10 mg, lot APX-2026-0816-C. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for Cagrilintide - 10 mg, lot APX-2026-0816-C. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

Cagrilintide - 5 mg

Lot
APX-2026-0815-C
COA issued
Aug 15, 2026
Issuing laboratory
Apex Laboratory
Cagrilintide chromatographic purity
99.911 % integrated detector area
Cagrilintide active content
4.99975 mg/vial
Amylin receptor cAMP response relative potency
100.05 % reference response potency
Bacterial endotoxins
<0.025 EU/mg active-equivalent

Chromatographic purity by analyte

Chromatographic purity by analyte for Cagrilintide - 5 mg, lot APX-2026-0815-C. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for Cagrilintide - 5 mg, lot APX-2026-0815-C. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

Cagrilintide is a amylin receptor agonist supplied by Apex Laboratory as a high-purity research peptide intended strictly for in-vitro laboratory research and development applications.

Compound Overview

Cagrilintide is an acylated, long-acting analog of human amylin. It binds amylin receptors (AMY1, AMY2, AMY3) and calcitonin receptors, modulating appetite, gastric emptying, and postprandial glucose signaling. Its fatty acid acylation extends research half-life through albumin binding.

Research Background & Published Literature

Frias and colleagues compared clinical cagrilintide, semaglutide and their co-administration in a type 2 diabetes trial. A combination result is distinct from a cagrilintide-alone result. This study does not validate the purity, activity, human use or biological outcome of the research-use cagrilintide supplied here.

Researchers interested in the published literature surrounding this compound can explore the following peer-reviewed resources for additional context on its mechanism of action, signaling pathways, and experimental applications in controlled laboratory settings:

Technical Specifications

  • Product Name: Cagrilintide
  • Classification: Amylin Receptor Agonist
  • Structural Description: Long-acting amylin analog, acylated synthetic peptide
  • CAS Number: 1415456-99-3
  • Molecular Weight: 3754.3 Da
  • Purity: ≥99% (verified by HPLC and Mass Spectrometry)
  • Physical Form: Lyophilized (freeze-dried) powder
  • Intended Use: In-vitro research use only — not for human consumption

Storage, Handling & Stability Guidelines

Store lyophilized at -20°C. Reconstituted at 2–8°C, use within 14 days.

  • Minimize time at ambient temperature during handling to preserve compound integrity.
  • Avoid moisture exposure by resealing vials promptly after each withdrawal.
  • Use appropriate personal protective equipment and follow your institution’s chemical safety protocols at all times.
  • Label all aliquots with the compound name, concentration, date of reconstitution, and operator initials for complete traceability.

Quality Assurance & Analytical Verification

Review the tests recorded for the applicable configuration and lot. The published Apex Laboratory record identifies the issuer, methods, results, units and acceptance criteria. A public configuration record does not by itself identify the lot currently shipping or establish independent accreditation.

Frequently Asked Questions

What is the relationship between Cagrilintide and CagriSema?

CagriSema is a research combination of Cagrilintide (amylin analog) and Semaglutide (GLP-1 agonist). Cagrilintide is the amylin component, studied for its complementary signaling alongside GLP-1 receptor activation.

What receptors does Cagrilintide target?

Cagrilintide targets amylin receptors (AMY1, AMY2, AMY3) and calcitonin receptors, modulating appetite, gastric emptying, and glucose signaling pathways.

Is this product approved for human use?

No. All compounds sold by Apex Laboratory are classified as chemical research reagents intended strictly for in-vitro laboratory research. They are not approved for human consumption, veterinary use, or any therapeutic application. Purchasers who imply intended bodily use will have their orders cancelled and accounts permanently suspended.

What documentation is available for this compound?

Open the applicable published configuration and lot record in the COA library. Read its issuer, methods, results, units and reporting limits, and match the complete lot on your material. If a particular lot or additional documentation is required, contact support before ordering; publication alone does not identify the lot that will ship.

Is bulk ordering available?

Yes. For bulk quantities, custom packaging requirements, or recurring supply agreements, contact our team with the compound name, desired quantity, preferred research-material format, and your target delivery timeline. Volume pricing is available for qualifying orders.

Related Research Compounds

Researchers studying amylin receptor agonist pathways may also be interested in related compounds available from Apex Laboratory, including Cagrisema (2.5mg+2.5mg), Semaglutide, Tirzepatide. Explore our complete research catalog to browse all available peptides, reagents, and laboratory supplies, or visit our About page to learn more about our quality verification process.

Shipping, Packaging & Delivery

Orders with cleared payment before 2:00 PM ET on a business day usually ship the same business day. Payment, address or inventory review and carrier conditions can affect timing. Review the shipping information for handling exceptions and current delivery estimates. Contact support before ordering if your research requires a particular packaging or shipping condition.

Research Use Disclaimer

For in-vitro research use only. Not for human consumption. All products sold by Apex Laboratory are intended exclusively for qualified researchers, accredited laboratories, and educational institutions. Purchasers assume full responsibility for ensuring safe handling, proper storage, and compliance with all applicable federal, state, and local laws, regulations, and institutional policies governing the purchase and use of chemical research reagents.

Vial size

5mg, 10mg

Latest published COA configuration Cagrilintide - 10 mg
Latest published COA lot APX-2026-0816-C
COA issue date 2026-08-16
Issuing laboratory Apex Laboratory
COA approved by K. Norwood